Axonics, Inc.

NASDAQ:AXNX

68.83 (USD) • At close September 6, 2024
Bedrijfsnaam Axonics, Inc.
Symbool AXNX
Munteenheid USD
Prijs 68.83
Beurswaarde 3,518,458,823
Dividendpercentage 0%
52-weken bereik 48.3 - 69.68
Industrie Medical Devices
Sector Healthcare
CEO Mr. Raymond W. Cohen
Website https://www.axonics.com

An error occurred while fetching data.

Over Axonics, Inc.

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM

Vergelijkbare Aandelen

OPKO Health, Inc. logo

OPKO Health, Inc.

OPK

1.56 USD

Insmed Incorporated logo

Insmed Incorporated

INSM

71.04 USD

Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

IOVA

10.01 USD

EQRx, Inc. logo

EQRx, Inc.

EQRX

2.34 USD

AdaptHealth Corp. logo

AdaptHealth Corp.

AHCO

11.1 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

23.31 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

31.54 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

1.62 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

24.4 USD

Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc.

HRMY

35.59 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)